Illumina Buys Helixis for Up to $105M; Unveils Sub-$15K Benchtop PCR Platform
July 29, 2010
Illumina Buys Helixis for Up to $105M; Unveils Sub-$15K Benchtop PCR Platform
Illumina has acquired real-time PCR and nucleic acid-analysis firm Helixis for up to $105 million, and has launched a new benchtop PCR instrument developed by Helixis that it said will cost about a quarter the price of existing systems while delivering the same level of performance.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina Reaches 1K Mark for Eco PCR Sales; Plans to Focus More on 'Low-Plex' Platforms
October 27, 2011 / PCR Insider - Illumina Logs 60-Plus Sales of Real-Time PCR System in First Full Quarter of Availability
October 28, 2010 / PCR Insider - Illumina Names VWR as US Distributor for qPCR Products
November 12, 2012 / GenomeWeb Daily News - Illumina Ships Record Number of Eco Real-Time PCR System in Q2
July 28, 2011 / PCR Insider - Illumina Expects to Resolve Eco PCR System Backlog by End of June
April 28, 2011 / PCR Insider